The page is the record's research on the issuer — no analyst, no rating, no view. # IDEAYA Biosciences, Inc. (NASDAQ: IDYA) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing IDEAYA Biosciences, Inc. is listed on NASDAQ under ticker IDYA. Its ISIN is US45166A1025 and its LEI is 549300ULW08F62IJML11. The security type is Corporate. The segment is not on the record. The sector is 2834 Pharmaceutical Preparations and the jurisdiction is United States, Delaware. The status is listed, not halted. ## The disclosure read The record holds 55 filings in the twelve months to 2026-11-08, on 32 filing days. The median gap between filing days is 8 days. The latest filing is dated 2026-11-03, 5 days before the record date, and is a regulatory filing. The NASDAQ median is 52 filings, 6.0 days of cadence gap and 5.0 days of latency across 4359 issuers. The sector median is 63.0 filings, 6.0 days of cadence gap and 4.0 days of latency across 526 issuers. ## Auditor The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change events. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04. ## Coverage The issuer's investor-relations page names 18 research houses: BTIG, Cantor Fitzgerald, Citi, Citizens JMP, Goldman Sachs, Guggenheim Securities, Jefferies, JP Morgan, Leerink Partners LLC, LifeSci Capital, Mizuho Securities, RBC Capital Markets, Stifel, TD Securities, Truist Securities, UBS, Wedbush and William Blair. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin) - https://data.sec.gov/submissions/CIK0001676725.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/IDYA (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://ir.ideayabio.com/analyst-coverage (coverage) - https://mcp.us-cm-kg.ai/record/NASDAQ/IDYA (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/IDYA · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp